XML 43 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Cash, Cash Equivalents and Available for Sale Securities - Narrative (Details)
Sep. 30, 2020
USD ($)
patient
Dec. 31, 2019
USD ($)
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 122,819,000 $ 125,699,000
Cash 3,700,000 3,200,000
Investments in money market funds, U.S. Treasury securities and certain short-term investment-grade corporate debt securities with original maturities of 90 days or less 119,100,000 122,500,000
Available for sale securities $ 108,303,000 $ 0
GATHER2 Trial    
Cash and Cash Equivalents [Line Items]    
Number Of Patients Planned To Enroll In Trial | patient 400